DGX
Overvalued by 4.5% based on the discounted cash flow analysis.
Market cap | $18.84 Billion |
---|---|
Enterprise Value | $25.21 Billion |
Dividend Yield | $3 (1.77756710315814%) |
Earnings per Share | $7.8 |
Beta | 0.89 |
Outstanding Shares | 111,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 21.51 |
---|---|
PEG | 137.65 |
Price to Sales | 1.95 |
Price to Book Ratio | 2.82 |
Enterprise Value to Revenue | 2.55 |
Enterprise Value to EBIT | 22.63 |
Enterprise Value to Net Income | 19 |
Total Debt to Enterprise | 0.27 |
Debt to Equity | 1.02 |
No data
No data
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy beh...